Preradiation chemotherapy in advanced medulloblastoma a pediatric oncology group pilot study
β Scribed by Askold D. Mosijczuk; Michael A. Nigro; Patrick R. M. Thomas; Peter C. Burger; Jeffrey P. Krischer; Robert A. Morantz; Beth Kurdunowicz; Arlynn F. Mulne; Richard B. Towbin; Arnold I. Freeman; Elise D. Nigro; Henry S. Friedman; Larry E. Kun
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 760 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Forty-six evaluable pediatric patients with primary recurrent brain tumors resistant to standard therapy were treated with cisplatin, 60 mg/m\*/day, X2 days every 3 to 4 weeks, to study the efficacy and toxicity of this drug. Complete and partial responses, documented by computed tomography (CT) sca
Background. The objectives of this study were to compare vincristine/actinomycin D/cyclophosphamide/adriamycin (VACA) with VACA plus imidazole carboxamide (DTIC) (VACAD) therapy in regards to complete/partial response and event free survival rates in children and adolescents with metastatic non-rhab
## Abstract This report updates experience with the CONPADRIβI, COMPADRIβII, and COMPADRIβIII adjuvant chemotherapy programs for the treatment of nonmetastatic osteosarcoma. A total of 200 patients received one of the three regimens. The analysis of response to treatment is based on diseaseβfree su